Selected article for: "molecule inhibitor and small molecule inhibitor"

Author: Sievers, Stuart A.; Scharf, Louise; West, Anthony P.; Bjorkman, Pamela J.
Title: Antibody engineering for increased potency, breadth and half-life
  • Document date: 2015_4_15
  • ID: zer0u60z_23
    Snippet: In addition to traditional IgG architectures (Fig. 2a) , other scaffolds have been used to achieve bispecific recognition. Small molecules can be conjugated to IgGs to create bifunctional reagents (Fig. 2b) ; for example conjugating cholesterol to the light chains of the anti-MPER bNAbs 2F5 and D5 enhanced their potencies through cholesterol-mediated interactions with the viral membrane [99] . In another study, a small-molecule inhibitor of viral.....
    Document: In addition to traditional IgG architectures (Fig. 2a) , other scaffolds have been used to achieve bispecific recognition. Small molecules can be conjugated to IgGs to create bifunctional reagents (Fig. 2b) ; for example conjugating cholesterol to the light chains of the anti-MPER bNAbs 2F5 and D5 enhanced their potencies through cholesterol-mediated interactions with the viral membrane [99] . In another study, a small-molecule inhibitor of viral entry, aplaviroc, was conjugated to the Fc to enhance neutralization potency [100] .

    Search related documents:
    Co phrase search for related documents
    • Fc conjugate and viral entry: 1
    • light chain and neutralization potency: 1, 2, 3
    • light chain and small molecule: 1, 2
    • light chain and small molecule inhibitor: 1
    • light chain and viral entry: 1, 2, 3, 4, 5, 6, 7
    • light chain and viral membrane: 1, 2
    • neutralization potency and viral entry: 1, 2, 3, 4
    • neutralization potency and viral membrane: 1, 2, 3
    • small molecule and viral entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54
    • small molecule and viral membrane: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • small molecule inhibitor and viral entry: 1, 2, 3, 4, 5
    • small molecule inhibitor and viral membrane: 1, 2